shot-button
Subscription Subscription
Home > News > World News > Article > UN peacekeeper in Liberia tests positive for Ebola

UN peacekeeper in Liberia tests positive for Ebola

Updated on: 05 December,2014 06:53 PM IST  | 
PTI |

A UN peacekeeper who contracted Ebola in Liberia will be flown to the Netherlands for treatment, a Dutch Health Ministry spokeswoman said today

UN peacekeeper in Liberia tests positive for Ebola

Monrovia: A UN peacekeeper who contracted Ebola in Liberia will be flown to the Netherlands for treatment, a Dutch Health Ministry spokeswoman said today.


The Nigerian soldier will go into isolation at a "calamity unit" at the University Medical Center Utrecht, according to Inge Freriksen. He is expected to arrive in Amsterdam over the weekend and be transferred by ambulance to nearby Utrecht.

Late Thursday, the UN mission announced that the soldier had tested positive for the dreaded disease a day earlier. This is the third case of Ebola among mission personnel, according to Karin Landgren, the top UN envoy in the country.


The previous two died. The mission has so far identified 16 people who came into contact with the soldier, and they have been quarantined, she said. Areas the peacekeeper visited while symptomatic have been decontaminated.


The man will be the first Ebola patient hospitalised in the Netherlands. He is being treated in a Dutch hospital at the request of the World Health Organisation, Freriksen said.

The Ebola outbreak has sickened nearly 17,300 people, mostly in Guinea, Liberia and Sierra Leone. Of those, about 6,100 have died.
The UN force, with about 7,700 troops and police, has been in Liberia since 2003 to bring stability after two civil wars.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK